Social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease

dc.contributor.authorEfil, Sevda
dc.contributor.authorBükrük, Ceren Mina
dc.contributor.authorÖzen, Ebru
dc.date.accessioned2024-12-21T20:06:43Z
dc.date.available2024-12-21T20:06:43Z
dc.date.issued2024-12
dc.descriptionThis research was conducted in conformity with ethical principles and the Helsinki Declaration. The Scientific Research Ethics Committee approved this research under the decision numbered 20/16, dated 24 November 2022. Participation was voluntary, anonymous, and did not involve any compensation. Informed consent was obtained from all the patients who were willing to participate in the study.
dc.description.abstractIntroduction and aim. The association between social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease is unclear. The aim of this study was to show the correlation of social vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease. Material and methods. Data collection was conducted by face to face interview in November 2022 and May 2023. Social vulnerability and medication adherence were evaluated using the Social Vulnerability Scale and the Medication Adherence Report Scale respectively. Results. The mean scores of individuals with chronic obstructive pulmonary disease for social vulnerability and medication adherence were 20.02±6.69 and 22.76±3.29 respectively. Levels of social vulnerability varied according to comorbidity, hypertension, heart failure, visit to emergency service in the last three months due to COPD exacerbation, and using herbal products instead of medication (p<0.05). Mean scores for medication adherence were lower in women, never smokers, and those who used herbal products instead of medication (p<0.05). Conclusion. Having a higher level of social vulnerability is associated with worse medication adherence (r=-0.31, p<0.01). Individuals using herbal products are found to be at risk for social vulnerability and non-adherence to medication (p<0.05).eng
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 22, z. 4 (2024), s. 776–784
dc.identifier.doi10.15584/ejcem.2024.4.13
dc.identifier.eissn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/11160
dc.language.isoeng
dc.publisherPublishing Office of the University of Rzeszow
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectchronic obstructive pulmonary disease
dc.subjectfrailty
dc.subjectmedication adherence
dc.subjectsocial vulnerability
dc.titleSocial vulnerability and medication adherence in individuals with chronic obstructive pulmonary disease
dc.typearticle

Pliki

Oryginalny pakiet

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
8.social_vulnerability_and_medication_adherence_in_individuals.pdf
Rozmiar:
223.52 KB
Format:
Adobe Portable Document Format

Pakiet licencji

Aktualnie wyświetlane 1 - 1 z 1
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis: